To answer this question, a multinational retrospective cohort study published in Ophthalmology Science in 2025 compared glucagon-like peptide-1 receptor agonists, or GLP-1 receptor agonists, with dipeptidyl peptidase-4 inhibitors, or DPP-4 inhibitors
fewer physical symptoms Weeks 6-8: Significant improvement in both physical and mental anxiety symptoms Weeks 8-12: Full therapeutic benefits typically emerge Patience during those initial weeks pays off with more stable, long-lasting relief
Combined therapy also delivers greater improvements in A1c and fasting glucose
This guide will walk you through the current options, future availability, and how Gard Wellness can help you with weight loss treatments, including other proven peptides like semaglutide and tirzepatide
Guilt compounded her grief when her attempts to resuscitate her youngest brother failed
Communicate openly with your partner